Skip to main content
Log in

Lithium use during pregnancy needs balanced decision making

  • Review
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The lithium-exposed group comprised pregnant women with lithium exposure during the index pregnancy. The mood-disorder reference group comprised pregnant women with a known history of mood disorder (i.e. bipolar disorder or major depressive disorder), without exposure to lithium from 90 days before pregnancy until delivery.

References

  1. Munk-Olsen T, et al. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. The Lancet Psychiatry : [9 pages], 18 Jun 2018. Available from: URL: http://dx.doi.org/10.1016/S2215-0366(18)30180-9.

  2. Galbally M, et al. Designing research that can untangle the effects in pregnancy of pharmacological treatments for mental disorders. The Lancet Psychiatry : [2 pages], 18 Jun 2018. Available from: URL: http://dx.doi.org/10.1016/S2215-0366(18)30214-1.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lithium use during pregnancy needs balanced decision making. Reactions Weekly 1708, 10 (2018). https://doi.org/10.1007/s40278-018-48103-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-48103-3

Navigation